BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17359293)

  • 1. PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells.
    Wan X; Li J; Xie X; Lu W
    Int J Gynecol Cancer; 2007; 17(4):808-12. PubMed ID: 17359293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity of PTEN gene-transfected endometrial carcinoma cell line to doxorubicin-induced apoptosis].
    Wan XY; Mao YY; Yokoyama Y
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):513-5. PubMed ID: 16438844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway.
    Wan X; Yokoyama Y; Shinohara A; Takahashi Y; Tamaya T
    Cell Death Differ; 2002 Apr; 9(4):414-20. PubMed ID: 11965494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Xiao L; Yang YB; Shen HM; Xu CF; Wang XY; Li XM
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ; Wei LH; Li XP; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
    Zhuo Z; Yu H
    Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1alpha in endometrial carcinoma cells with expression of suppressor endoprotein PTEN.
    Li XP; Zhao D; Gao M; Zhao C; Wang JL; Wei LH
    Chin Med J (Engl); 2006 Mar; 119(5):378-83. PubMed ID: 16542580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL; Yokoyama Y; Wan X; Iwagaki S; Niwa K; Tamaya T
    Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.
    Li T; Yang Y; Li X; Xu C; Meng L
    Mol Cell Biochem; 2012 Feb; 361(1-2):19-29. PubMed ID: 21952748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
    Gagnon V; St-Germain ME; Parent S; Asselin E
    Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
    Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy.
    Xiao L; Yang YB; Li XM; Xu CF; Li T; Wang XY
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):1089-99. PubMed ID: 20087603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
    Zhou C; Bae-Jump VL; Whang YE; Gehrig PA; Boggess JF
    Gynecol Oncol; 2006 May; 101(2):305-10. PubMed ID: 16380156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME; Gagnon V; Parent S; Asselin E
    Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
    Zhang G; Hou X; Li Y; Zhao M
    BMC Cancer; 2014 Jun; 14():440. PubMed ID: 24929707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRĪ³ through AKT and ERK1/2.
    Sun Y; Wang C; Yang H; Ma X
    Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
    Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
    Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.
    Dida F; Li Y; Iwao A; Deguchi T; Azuma E; Komada Y
    Exp Hematol; 2008 Oct; 36(10):1343-53. PubMed ID: 18599181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.